Knockdown of SphK2 expression increases the sensitivity of cancer cells to chemotherapy [18–20], while chemical inhibition can reduce cancer cell growth in vitro [21–28] and in pre-clinical animal models [21, 24, 26]. This evidence concerns the gene SPHK2 and cancer.